Your browser doesn't support javascript.
Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalized patients with acute COVID-19.
Pan, Daniel; Kim, Jee Whang; Nazareth, Joshua; Assadi, Sara; Bellass, Adam; Leach, Jack; Brosnan, James G; Ahmed, Adam; Starcevic, Fleur; Sze, Shirley; Martin, Christopher A; Williams, Caroline M; Barer, Michael R; Sahota, Amandip; Patel, Prashanth; Tattersall, Andrea; Cooper, Andrea; Pareek, Manish; Haldar, Pranabashis.
  • Pan D; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom. Electronic address: daniel.pan@nhs.net.
  • Kim JW; Department of Respiratory Sciences, University of Leicester, United Kingdom; Respiratory Biomedical Research Center, University of Leicester, United Kingdom.
  • Nazareth J; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Assadi S; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Bellass A; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Leach J; University of Leicester Medical School, United Kingdom.
  • Brosnan JG; University of Leicester Medical School, United Kingdom.
  • Ahmed A; University of Leicester Medical School, United Kingdom.
  • Starcevic F; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Sze S; Department of Cardiovascular Sciences, University of Leicester, United Kingdom.
  • Martin CA; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Williams CM; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Microbiology, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Barer MR; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Microbiology, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Sahota A; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Patel P; Department of Chemical and Metabolic Diseases, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Tattersall A; Oxford Immunotec Ltd, United Kingdom.
  • Cooper A; Department of Respiratory Sciences, University of Leicester, United Kingdom; Trudeau Institute, Saranac Lake, New York, USA.
  • Pareek M; Department of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
  • Haldar P; Department of Respiratory Sciences, University of Leicester, United Kingdom; Respiratory Biomedical Research Center, University of Leicester, United Kingdom.
J Infect ; 84(3): 418-467, 2022 03.
Article in English | MEDLINE | ID: covidwho-1596740
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article